Esophageal cancer brachytherapy applicator consists of multiple independently controlled balloons. It is designed to fit most commercially available after-loading platform.

• Ÿ   Minimally Invasive & Efficient：

A NG tube-sized diameter that allows for transnasal placement in an outpatient setting without the need for anesthesia. This streamlined approach typically allows the entire procedure to be completed within one hour, significantly reducing the clinical and administrative burden.

• Ÿ   Precision and Stability：

Features multiple independently inflatable balloons to ensure optimal centering within the lumen and consistent mucosal contact, enhancing dose distribution accuracy.

Medical Device Approval：

Ÿ   Taiwan: Class II Medical Device (MOHW-MD-No.006603)

Ÿ   US: Class II Medical Device (FDA 510(k): K243045)

Ÿ   Japan: Class III Medical Device (PMDA: 306ADBZX00007000)